Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 20, 2025Journal of Clinical MedicineOpen Access

Integrating and Simplifying Evidence to Optimize Cardiorenal Guideline-Directed Therapies

View Full Paper
Ask AI
Bookmark
Share

Authors

HSHarleen SinghCPCarrie PuckettYLY. Lucas

Discussion

Loading...

Member takes

Overview

Evidence suggests enhancing guideline-directed therapies improves outcomes in chronic kidney disease and heart failure, indicating a need for better integration of care.

Key Points

  • Optimizing guideline-directed therapies significantly benefits individuals with chronic kidney disease and heart failure, improving their overall outcomes.
  • Recent evidence underscores the role of emerging treatments like sodium–glucose cotransporter 2 inhibitors in managing chronic kidney disease effectively.
  • Cardiorenal syndrome complicates treatment, as chronic kidney disease and heart failure share risk factors and can exacerbate each other's conditions.
  • Improved early detection and management strategies for chronic kidney disease are crucial to reduce mortality and enhance patient quality of life.

Cite This Study

Singh et al. (2025) studied this question.

synapsesocial.com/papers/68af3e4fcf1dd9ea359eb93fhttps://doi.org/10.3390/jcm14165883
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evolving strategies for early diagnosis, proactive prevention and treatment of CKD2025 · 12 citations
  2. 2The Association of Chronic Kidney Disease with Increased Cardiovascular Morbidity and Mortality: A Systematic Review2025 · 1 citations
  3. 3Hypertension in Advanced Chronic Kidney Disease: Saving the Kidneys or the Heart?2026
  4. 4Overcoming Renalism: A Roadmap Towards Equitable Kidney Care2025
  5. 5Updates in management of cardiorenal syndrome2026